How to Audit Practitioner Prescribing Records

A prescribing outlier alone does not establish improper prescribing. However, it can prompt a closer, documented review before a complaint, patient-safety event, diversion concern, or DEA inquiry arises. A risk-based prescribing audit can help healthcare organizations identify patterns, assess whether clinical documentation and applicable requirements support prescribing decisions, and address control gaps. The appropriate scope and frequency depend on the organization, applicable law, and internal policy.

For DEA registrants and organizations that oversee controlled substances, a prescribing audit should not be treated as a billing exercise or a search for the highest prescriber. It is a risk-based review of whether the clinical record supports prescribing activity, aligns with the practitioner's role and patient population, and is subject to appropriate internal controls. The audit should document the question reviewed, the evidence considered, and any actions taken in response to identified concerns.

Start With a Defined Audit Purpose and Scope

An audit is most useful when its purpose is clear. Before collecting records, define the question the organization needs to answer. A review may be prompted by unusual controlled-substance volume, repeated early refill requests, employee concerns, a prescribing complaint, an adverse event, a DEA registration issue, or a routine compliance plan.

The scope should reflect the risk and the question being reviewed. A focused audit may examine one practitioner, one drug class, one location, or a defined period. A broader review may compare practitioners across specialties or sites. For controlled substance oversight, review prescription activity alongside relevant clinical documentation, dispensing or administration records, prescription drug monitoring program information where permitted and available, and internal reports of losses, discrepancies, or patient concerns.

Choose a review period long enough to distinguish a temporary spike from a sustained pattern. Six to 12 months may work for some reviews, while a shorter period may suit an immediate concern. Document why the organization selected the scope, data sources, and sample methodology. That record can help explain how the review was designed and what its findings cover.

How to Audit Practitioner Prescribing Records Systematically

A sound review moves from data to context to findings. Identify patterns that warrant validation, then assess whether the clinical record and organizational controls support the prescribing activity. Do not assume high volume alone demonstrates noncompliance.

Establish a reliable data set.

The audit team should understand what each data source represents and its limitations. Obtain prescribing data from the electronic health record, e-prescribing platform, pharmacy records, or another reliable source. Confirm that practitioner identifiers are accurate, address duplicate patient records, and, when the data allows, distinguish canceled prescriptions from dispensed prescriptions. Define how refill activity will be counted so that prescribing patterns are measured consistently across the audit.

For each selected prescription, capture only the information needed to answer the audit question. This may include the patient identifier, date, drug, strength, quantity, directions, refill information, diagnosis or indication when available, prescriber, location, and payment information when relevant to the identified risk. For controlled substances, include the schedule and formulation. Immediate-release and extended-release products may carry different clinical implications and should not be treated as interchangeable data points.

Treat data quality as an internal control issue, not a technical inconvenience. Incomplete fields, inconsistent practitioner attribution, or disconnected systems can conceal patterns the audit is intended to identify. Document data limitations in the work papers and account for them when drawing conclusions.

Screen for meaningful risk indicators

Comparisons are useful when they are fair. Evaluate prescribing patterns against those of similarly situated practitioners, accounting for specialty, clinical setting, patient acuity, service line, and authorized scope of practice. Do not measure an emergency physician, pain specialist, hospice provider, surgeon, and primary care practitioner against the same baseline.

Indicators that may warrant closer review include unusually high controlled substance volume, high-dose prescribing patterns, combinations of medications associated with elevated overdose risk, repeated early refill requests, frequent replacement prescriptions, cash-pay patterns when relevant to the identified risk, unusual patient travel patterns, and prescriptions written outside normal practice hours. Along with prescribing to employees, family members, or others where a potential conflict of interest exists. Multiple prescribers or pharmacies may also warrant attention, depending on the information available.

These indicators are signals, not conclusions. Some may have legitimate explanations supported by the practitioner's patient population, clinical settings, and documentation. The audit should distinguish explainable variation from concerns that warrant further review or action. Once you identify a prescribing pattern, determine whether the clinical record and applicable requirements support the activity.

Review the clinical and regulatory record together.

For each sampled encounter, assess whether the available record supports a legitimate medical purpose and prescribing in the usual course of professional practice. The documentation should reasonably connect the patient's condition, assessment, treatment plan, prescribed medication, and follow-up plan.

Review whether the practitioner documented relevant history, examination findings when appropriate, risk factors, treatment alternatives, monitoring, and response to therapy. For ongoing controlled substance therapy, look for evidence of periodic reassessment rather than routine continuation without review. The appropriate level of clinical detail depends on the setting, specialty, medication, and the patient's condition. A chart review should not impose a one-size-fits-all documentation standard.

Also assess operational compliance. Verify that required prescription elements are present, the practitioner has current authority to prescribe in the relevant setting, electronic prescribing controls are functioning as intended, and any delegated or refill processes are authorized and documented. Assess federal requirements, state law, professional licensing rules, organizational policy, and payer obligations separately; they may overlap, but they are not identical.

Test for internal-control breakdowns

Audits can identify process failures and individual concerns. A practitioner may exercise sound clinical judgment while the organization has gaps in credentialing, prescribing access, monitoring, or escalation.

Examine whether prescribing privileges align with the practitioner's role and applicable registration or prescribing authority. Confirm that terminated or inactive users lose access promptly, audit logs are reviewed when concerns arise, and prescribing credentials are protected from unauthorized use. If staff process refills under delegated authority, clarify who is responsible and confirm the practitioner provides appropriate oversight.

Consider whether staff know how to report concerning prescribing behavior and can do so without fear of retaliation. A policy that exists but goes unused or unenforced may provide little practical protection during an inspection or investigation.

Document Findings With Precision

Audit reports should distinguish among observations, confirmed noncompliance, and unresolved concerns. Avoid broad statements such as “poor prescribing practices.” Instead, identify the records reviewed, the relevant date range, the applicable policy or requirement, the specific concern, and the supporting evidence.

A well-supported finding describes the observed condition, explains the associated risk, identifies the applicable requirement or control, and recommends an appropriate corrective action. For example, selected records for patients receiving ongoing controlled-substance therapy may lack documentation of reassessment at intervals set by organizational policy. As a result, the organization may be unable to demonstrate the oversight its policy requires.

Use a risk-ranking method that considers both potential impact and likelihood. Depending on the evidence and patient-safety needs, urgent concerns may require prompt review by medical leadership, a patient-safety evaluation, temporary prescribing restrictions, or consultation with legal counsel. Lower risk documentation gaps may be addressed through training, revised templates, and follow-up monitoring. Match the response to the findings.

Turn the Audit Into Corrective Action

An audit should lead to follow-through. Assign corrective actions to named owners, set deadlines, and define the evidence that shows each action is complete. Depending on the findings, actions may include focused education, policy revision, enhanced supervision, credentialing review, access-control changes, peer review, documentation improvements, or a broader assessment of controlled-substance controls.

Reaudit after corrective action to confirm the identified gap was addressed and that the change did not create new problems. For example, an overly restrictive refill workflow may reduce inappropriate renewals but also delay legitimate patient care. Controls need to be workable so staff can follow them consistently.

Preserve audit workpapers, reports, corrective-action documentation, and leadership oversight records according to applicable retention policies. Do not assume that federal controlled-substance record retention periods apply to every internal audit file. Limit access to personnel with a legitimate need to know, and address privacy, confidentiality, peer-review protections where applicable, and legal considerations with internal counsel.

When Independent Review Adds Value

An internal audit may be a suitable first step if the organization has experienced compliance personnel and a well-defined concern. Independent review may add value when allegations involve senior leadership, prescribing patterns present material regulatory or diversion risk, internal teams lack relevant expertise, or prior corrective actions have not resolved the issue.

An experienced outside reviewer can provide an independent perspective, challenge assumptions, identify gaps that routine internal reviews may overlook, and help the organization prioritize corrective actions before concerns escalate.

A prescribing audit should establish facts, support patient safety, and give leadership a clear basis for action. Its purpose is to identify and address concerns proportionately, while recognizing that an outlier alone does not establish improper prescribing.